If you need more lookups,
subscriptions start at $34 USD/month.
Wei Lin Location
Redwood City, CA, US
Wei Lin Work
Chief Medical Officer @ (April 2023 - Present)
Board Member @ (March 2023 - Present)
Chief Medical Officer @ (January 2021 - April 2023)
Senior Vice President and Head of Development @ (October 2019 - January 2021)
Senior Vice President and Head of Oncology @ (October 2018 - September 2019)
Global Development Leader, Cancer Immunotherapy, Lung Cancer @ (January 2018 - October 2018)
Global Clinical Leader, Cancer Immunotherapy, Lung Cancer @ (April 2017 - October 2018)
Senior Medical Director @ (March 2015 - August 2018)
Site Head for Product Development Oncology in Asia Pacific @ (April 2015 - August 2017)
Medical Director @ (September 2014 - March 2015)
Associate Medical Director @ (September 2013 - September 2014)
Assistant Medical Director @ (September 2011 - September 2013)
Faculty @ (September 2009 - September 2011)
Fellow @ (September 2006 - September 2009)
Resident @ (June 2004 - June 2006)
Tutor @ (September 2000 - June 2001)
Wei Lin Education
Harvard Medical School
MD (Medicine)
Haverford College
Bachelor's degree (Physics)
Wei Lin Skills
Clinical Development
Clinical Trials
Medical Affairs
Oncology
Medical Writing
Infectious Diseases
Hematology
Drug Development
Pharmacovigilance
Translational Medicine
Cancer
Immunology
Medical Research
Translational Research
Internal Medicine
Biotechnology
Oncology Clinical Research
Strategy
Medical Directors
Microsoft Word
Product Development
Leadership
Wei Lin Summary
Wei Lin, based in Redwood City, CA, US, is currently a Chief Medical Officer at REVOLUTION Medicines. Wei Lin brings experience from previous roles at 2seventy bio, Erasca, Inc. and Nektar Therapeutics. Wei Lin holds a MD in Medicine @ Harvard Medical School. With a robust skill set that includes Clinical Development, Clinical Trials, Medical Affairs, Oncology, Medical Writing and more. Wei Lin has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Wei Lin?
Find contact details for 700 million professionals.